Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Lymphoma, Non-Hodgkin × Quercetin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Triple Negative Breast Neoplasms 1 Mouth Neoplasms 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Follicular 1

Interventions

Cyclophosphamide 23 Rituximab 20 Etoposide 13 Cytarabine 13 Melphalan 11 Vincristine 9 Prednisone 8 Doxorubicin 8 Busulfan 8 Peripheral Blood Stem Cell Transplantation 7 Cyclosporine 7 fludarabine 6 Radiotherapy 6 Mycophenolic Acid 6 Filgrastim 6 Bendamustine Hydrochloride 6 fludarabine phosphate 5 Cisplatin 5 ibritumomab tiuxetan 4 Carmustine 4 tositumomab I-131 3 Thiotepa 3 Indium 3 Immunotherapy, Adoptive 3 Ifosfamide 3 Gemcitabine 3 Drug Therapy 3 Dexamethasone 3 Antilymphocyte Serum 3 thymoglobulin 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00455416 2008-05-21

KLYMF

Oslo University Hospital

Phase 2 Unknown

Lymphoma, Follicular, Lymphoma, Non-Hodgkin

Data powered by HemOnc (CC BY 4.0) Colophon ⚡